Global Innovative Platforms Inc. - Form 8-K Filing
Global Innovative Platforms Inc. filed a Form 8-K on June 15, 2026, reporting on recent corporate developments. The filing includes a shareholder update letter detailing progress in fundraising, scientific development, corporate governance, and strategic partnerships. The company is advancing its VetBreathβ’ Analytics, focusing on early detection of parasitic infections in animals through breath analysis. Key developments include progress on a 15c2-11 FINRA application for improved liquidity, ongoing studies for heartworm, hookworm, roundworm, whipworm, and Giardia detection, and expansion of operational capacity with a third VetBreath Dx analyzer. The company has secured a revenue-generating collaboration and has established a Board of Directors and an expanded Strategic Advisory Board with expertise in veterinary medicine and business. Global Innovative Platforms Inc. was also selected for the Plug and Play incubator program, winning a pitch competition, and has initiated a new collaboration with Big Dog Ranch Rescue for sample collection. The team has been expanded with Dr. Sarah Cutler Tew as Lead Clinical Development and Scientific Advisor. The company has sufficient capital for operations through the end of 2026 but acknowledges going concern considerations.